| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Nervous System Diseases | D009422 | 37 associated lipids |
| Red-Cell Aplasia, Pure | D012010 | 4 associated lipids |
Total
3
Fluoxymesterone
Fluoxymesterone is a lipid of Sterol Lipids (ST) class. Fluoxymesterone is associated with abnormalities such as Anemia. The involved functions are known as Stimulus. Fluoxymesterone often locates in Entire bony skeleton.
Cross Reference
Introduction
To understand associated biological information of Fluoxymesterone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Fluoxymesterone?
Fluoxymesterone is suspected in Anemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Fluoxymesterone
PubChem Associated disorders and diseases
What pathways are associated with Fluoxymesterone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Fluoxymesterone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Fluoxymesterone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Fluoxymesterone?
There are no associated biomedical information in the current reference collection.
What genes are associated with Fluoxymesterone?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Fluoxymesterone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Fluoxymesterone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lo TE et al. | Fluoxymesterone-induced gynaecomastia in a patient with childhood aplastic anaemia. | 2015 | BMJ Case Rep | pmid:25948845 |
| Surampudi PN et al. | Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. | 2012 | Int J Endocrinol | pmid:22505891 |
| Lu J et al. | Mass spectrometric identification and characterization of new fluoxymesterone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry. | 2012 | Steroids | pmid:22521423 |
| Zohoorian-Abootorabi T et al. | Separate and simultaneous binding effects through a non-cooperative behavior between cyclophosphamide hydrochloride and fluoxymesterone upon interaction with human serum albumin: multi-spectroscopic and molecular modeling approaches. | 2012 | Spectrochim Acta A Mol Biomol Spectrosc | pmid:22217702 |
| Fürstenberger C et al. | The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation. | 2012 | Toxicol. Sci. | pmid:22273746 |
| Donohoe CL et al. | Cancer cachexia: mechanisms and clinical implications. | 2011 | Gastroenterol Res Pract | pmid:21760776 |
| Pun T and Chandurkar V | Growth hormone deficiency, short stature, and juvenile rheumatoid arthritis in a patient with autoimmune polyglandular syndrome type 1: case report and brief review of the literature. | 2011 | ISRN Endocrinol | pmid:22363878 |
| Tazi E and Errihani H | Treatment of cachexia in oncology. | 2010 | Indian J Palliat Care | pmid:21218002 |
| Penel N et al. | Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care. | 2010 | Br. J. Cancer | pmid:20354522 |
| Ingle JN | Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer. | 2008 | Breast Cancer Res. | pmid:19128430 |